Protagonist Therapeutics
PTGX
PTGX
76 hedge funds and large institutions have $228M invested in Protagonist Therapeutics in 2019 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 29 increasing their positions, 18 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
9% more capital invested
Capital invested by funds: $208M → $228M (+$19M)
1.54% less ownership
Funds ownership: 73.6% → 72.06% (-1.5%)
Holders
76
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$9.15M | |
| 2 | +$5.47M | |
| 3 | +$5.2M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$2.15M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$2.12M |
Top Sellers
| 1 | -$4.58M | |
| 2 | -$3.32M | |
| 3 | -$3.04M | |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$1.47M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$1.23M |